» Articles » PMID: 19915009

N-linked Glycosylation is Essential for the Stability but Not the Signaling Function of the Interleukin-6 Signal Transducer Glycoprotein 130

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2009 Nov 17
PMID 19915009
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

N-Linked glycosylation is an important determinant of protein structure and function. The interleukin-6 signal transducer glycoprotein 130 (gp130) is a common co-receptor for cytokines of the interleukin (IL)-6 family and is N-glycosylated at 9 of 11 potential sites. Whereas N-glycosylation of the extracellular domains D1-D3 of gp130 has been shown to be dispensable for binding of the gp130 ligand IL-6 and its cognate receptor in vitro, the role of the N-linked glycans on domains D4 and D6 is still unclear. We have mutated the asparagines of all nine functional N-glycosylation sites of gp130 to glutamine and systematically analyzed the consequences of deleted N-glycosylation (dNG) in both cellular gp130 and in a soluble gp130-IgG1-Fc fusion protein (sgp130Fc). Our results show that sgp130Fc-dNG is inherently unstable and degrades rapidly under conditions that do not harm wild-type sgp130Fc. Consistently, the bulk of cellular gp130-dNG is not transported to the plasma membrane but is degraded in the proteasome. However, the small quantities of gp130-dNG, which do reach the cell surface, are still able to activate the key gp130 signaling target signal transducer and activator of transcription-3 (STAT3) upon binding of the agonistic complex of IL-6 and soluble IL-6 receptor. In conclusion, N-linked glycosylation is required for the stability but not the signal-transducing function of gp130.

Citing Articles

Study of the Effects of Deuterium-Depleted Water on the Expression of GLUT4 and Insulin Resistance in the Muscle Cell Line C2C12.

Kondo M, Sawada K, Matsuda Y, Abe M, Sanechika N, Takanashi Y Biomedicines. 2024; 12(8).

PMID: 39200235 PMC: 11351524. DOI: 10.3390/biomedicines12081771.


ART1 knockdown decreases the IL-6-induced proliferation of colorectal cancer cells.

Lin T, Zhang S, Tang Y, Xiao M, Li M, Gong H BMC Cancer. 2024; 24(1):354.

PMID: 38504172 PMC: 10953198. DOI: 10.1186/s12885-024-12120-0.


Expression and Clinical Significance of Plasma miR-223 in Patients with Diabetic Nephropathy.

Guo X, Huang M, Yang D, Luo Z Int J Endocrinol. 2024; 2023:9663320.

PMID: 38179188 PMC: 10764645. DOI: 10.1155/2023/9663320.


The gp130/STAT3-endoplasmic reticulum stress axis regulates hepatocyte necroptosis in acute liver injury.

Li X, Wang J, Li Y, He W, Cheng Q, Liu X Croat Med J. 2023; 64(3):149-163.

PMID: 37391912 PMC: 10332293.


Identification and characterization of a new variation in gene in two Chinese siblings with mild intellectual impairment.

Zhao P, Hu Y, Hu J, Li C, Huang Y, Zhang L Front Genet. 2023; 14:930692.

PMID: 37152991 PMC: 10154465. DOI: 10.3389/fgene.2023.930692.


References
1.
Boulanger M, Bankovich A, Kortemme T, Baker D, Garcia K . Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130. Mol Cell. 2003; 12(3):577-89. DOI: 10.1016/s1097-2765(03)00365-4. View

2.
Bravo J, Staunton D, Heath J, Jones E . Crystal structure of a cytokine-binding region of gp130. EMBO J. 1998; 17(6):1665-74. PMC: 1170514. DOI: 10.1093/emboj/17.6.1665. View

3.
Skiniotis G, Boulanger M, Garcia K, Walz T . Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor. Nat Struct Mol Biol. 2005; 12(6):545-51. DOI: 10.1038/nsmb941. View

4.
Narazaki M, Yasukawa K, Saito T, Ohsugi Y, Fukui H, Koishihara Y . Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood. 1993; 82(4):1120-6. View

5.
Rose-John S, Waetzig G, Scheller J, Grotzinger J, Seegert D . The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets. 2007; 11(5):613-24. DOI: 10.1517/14728222.11.5.613. View